_._. Chubenko

Obesity and metabolic syndrome

The Role of Hyperleptinemia in the Development of Abdominal Obesity, Insulin Resistance, and Arterial Hypertension and Approaches to Therapy

• Broschiertes Buch

Produktbeschreibung

Obesity is one of the most pressing medical problems. Abdominal obesity is often combined with high blood pressure, dyslipidemia and hyperglycemia, which have adverse cardiovascular consequences and are united by the term metabolic syndrome. This syndrome is characterized by decreased sensitivity of peripheral tissues to insulin, hyperinsulinemia, hyperleptinemia and leptin resistance, which is accompanied by endothelial dysfunction, oxidative stress, proinflammatory and prothrombotic disorders. The role of leptin and polymorphisms of the leptin gene and leptin receptor gene in the development of abdominal obesity and its adverse hemodynamic and metabolic consequences was determined in the present work. The work presents data on the use of imidazoline receptor agonists, particularly moxonidine, in the treatment of patients with hypertension and metabolic syndrome. The book is intended for cardiologists, endocrinologists, general practitioners, medical students.

Produktdetails

• Verlag: Our Knowledge Publishing
• Seitenzahl: 160
• Erscheinungstermin: 16. November 2021
• Englisch
• Abmessung: 220mm x 150mm x 10mm
• Gewicht: 256g
• ISBN-13: 9786203215793
• ISBN-10: 6203215791
• Artikelnr.: 62941606

Autorenporträt

Chubenko Ekaterina, Ph.D., assistant of the department. Baranova Elena, MD, DSc, Professor of the Department. Shlyakhto Evgeniy, MD, DSc, Corresponding Member of RAMS, Professor, Head Department of Faculty Therapy of the St. Petersburg State Med. University named after ac. I.P. Pavlova, Director of the Federal Center for Heart, Blood and Endocrinology named after I.P. V.A. Almazova